Want to join the conversation?
$C 2Q15 Call: When asked about GCB target, John said that Citigroup has not adjusted the target and believes that that business should be able to operate in an efficiency ratio of 49% to 52%. He added that the overall efficiency ratio for the business for this year is likely to be slightly higher than 52%, somewhere in the 52% to 53% range.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?